Franklin Resources’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
289,296
+24,402
+9% +$305K ﹤0.01% 1722
2025
Q4
$3.43M Buy
264,894
+14,582
+6% +$187K ﹤0.01% 1578
2025
Q3
$3.23M Buy
250,312
+73,363
+41% +$980K ﹤0.01% 1611
2025
Q2
$3.15M Buy
176,949
+3,990
+2% +$69.5K ﹤0.01% 1546
2025
Q1
$3.08M Buy
172,959
+16,895
+11% +$384K ﹤0.01% 1539
2024
Q4
$4.65M Sell
156,064
-24,789
-14% -$525K ﹤0.01% 1377
2024
Q3
$2.9M Buy
180,853
+124,793
+223% +$2.26M ﹤0.01% 1594
2024
Q2
$960K Sell
56,060
-455
-0.8% -$8K ﹤0.01% 1941
2024
Q1
$883K Buy
56,515
+2,220
+4% +$32.6K ﹤0.01% 2009
2023
Q4
$811K Buy
+54,295
New +$727K ﹤0.01% 1729
2023
Q3
Sell
-6,902
Closed -$286K 2747
2023
Q2
$286K Buy
6,902
+1,083
+19% +$67.2K ﹤0.01% 2227
2023
Q1
$350K Sell
5,819
-1,390
-19% -$111K ﹤0.01% 1812
2022
Q4
$529K Buy
7,209
+909
+14% +$68.4K ﹤0.01% 1684
2022
Q3
$478K Buy
6,300
+1,135
+22% +$88.5K ﹤0.01% 1695
2022
Q2
$360K Buy
5,165
+312
+6% +$23.5K ﹤0.01% 1814
2022
Q1
$402K Buy
4,853
+851
+21% +$62.7K ﹤0.01% 1909
2021
Q4
$301K Sell
4,002
-551
-12% -$55.3K ﹤0.01% 2079
2021
Q3
$528K Sell
4,553
-718
-14% -$109K ﹤0.01% 1863
2021
Q2
$1.17M Sell
5,271
-3,842
-42% -$747K ﹤0.01% 1453
2021
Q1
$1.21M Sell
9,113
-94,496
-91% -$14.9M ﹤0.01% 1441
2020
Q4
$17.9M Buy
103,609
+101,504
+4,822% +$13.9M 0.01% 834
2020
Q3
$234K Buy
+2,105
New +$168K ﹤0.01% 1625

Other funds holding NVCR